| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 05/19/2005 | CA2541212A1 Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 05/18/2005 | EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | EP1176139B1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors |
| 05/18/2005 | CN1617881A Chemical process |
| 05/18/2005 | CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/18/2005 | CN1617744A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 05/18/2005 | CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity |
| 05/18/2005 | CN1616452A 维生素d类似物 Vitamin d analogues |
| 05/18/2005 | CN1616432A Compound, its use and pharmaceutical compositions comprising same |
| 05/18/2005 | CN1616424A Novel ceramide compound with cell fading inducing activity and its preparing method |
| 05/18/2005 | CN1202113C Ru-polypyridine complex and its synthesizing process and use |
| 05/18/2005 | CN1202052C Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system |
| 05/18/2005 | CN1201735C Mycobacterial inhibitors |
| 05/17/2005 | US6894185 Substituted chiral allosteric hemoglobin modifiers |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/17/2005 | US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides |
| 05/17/2005 | US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine |
| 05/17/2005 | CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 05/12/2005 | WO2005042516A2 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/12/2005 | WO2005042489A1 N-substituted benzene sulfonamides |
| 05/12/2005 | WO2005042484A1 Preparation of 4,5-dialkyl-3-acyl-pyrrole-2-carboxylic acid derivatives by fischer-fink type synthesis and subsequent acylation |
| 05/12/2005 | WO2005042483A1 [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-((1-methylethyl) -3-phenyl-4-[(phenylamino) carbonyl]- 1h-pyrrole-1-heptanoic acid iron salt |
| 05/12/2005 | WO2005042482A1 Vitamin d3 lactam derivative |
| 05/12/2005 | WO2005042466A1 Quaternary ammonium salt, electrolyte, electrolyte solution and electrochemical device |
| 05/12/2005 | WO2005023765A8 Method for catalyzing amidation reactions by the presence of co2 |
| 05/12/2005 | WO2005018635A3 Ion channel modulating activity i |
| 05/12/2005 | WO2005014539A3 Pyrrole-based hmg-coa reductase inhibitors |
| 05/12/2005 | WO2003006454A8 Heterocyclic carboxamides and their use as fungicides |
| 05/12/2005 | US20050101783 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide |
| 05/12/2005 | US20050101760 reacting polyhydroxypropionate isolated from plant biomass with ammonia to form alkenoic amide (acrylamide, methacrylamide); depolymerization |
| 05/12/2005 | US20050101671 Compounds and compositions for delivering active agents |
| 05/12/2005 | US20050101663 Synthetic lactone formulations and method of use |
| 05/12/2005 | US20050101657 Pyrrole derivatives for preventing or treating cancer sensitive to hormones; administered with luteininzing hormone releasing hormone derivative |
| 05/12/2005 | US20050101651 Viricides; protease inbhibitors; useful for inhibiting the activity of picornaviral 3C proteases; for example, 6-carbamoyl-4S-{2S-[(5-naphthalen-1-yl-1H-pyrrole-2-carbonyl)-amino-3-phenyl-propionylamino}-hex-2(trans)-enoic acid ethyl ester |
| 05/12/2005 | US20050101644 Benzylether amine compounds useful as CCR-5 antagonists |
| 05/12/2005 | US20050101567 Using a sulfonamide containing compound |
| 05/12/2005 | CA2544725A1 Vitamin d3 lactam derivative |
| 05/12/2005 | CA2544350A1 N-substituted benzene sulfonamides |
| 05/11/2005 | EP1529529A1 Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for immunomodulation, immunostimulation and/or antiphlogistic treatment |
| 05/11/2005 | EP1529042A1 Arylamides |
| 05/11/2005 | EP1337532B1 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit |
| 05/11/2005 | EP1057485B1 Potassium channel activators |
| 05/11/2005 | CN1615311A 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 05/11/2005 | CN1615153A Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 05/11/2005 | CN1613857A Dipyrromethene metal chelate compounds |
| 05/11/2005 | CN1613853A PDF enzyme inhibitor-hydroxamic acid serial compounds synthetic method and use thereof |
| 05/11/2005 | CN1200930C New crystalline polymorphic form of 1-methyl-5-P-toluoylpyrroel-2-ac-etamidoacetic acid guaiacyl ester (MED 15) |
| 05/10/2005 | US6891071 Halogenated styrene compounds and very low-loss polymers made therefrom |
| 05/10/2005 | US6891047 Process for the preparation of amorphous atorvastatin |
| 05/10/2005 | US6891046 Solution and solid phase synthesis of pyrrolinones and polypyrrolinones |
| 05/10/2005 | US6890939 Aminopyrrolidine sulfonamides as serine protease inhibitors |
| 05/10/2005 | US6890932 Anthranilic acid derivative |
| 05/10/2005 | US6890921 Selectively inhibit binding to alpha-1a adrenergic receptor; 1-(2-phthalimidoethyl)-4-(2-isopropyloxyphenyl)piperazine; N-(Ethyl-2-(2-iso-propyloxyphenyl)piperazin-4-yl))-(1'-(2-oxy -piperdinyl))acetamidemide |
| 05/10/2005 | US6890362 Oxidation base chosen from certain para-phenylenediamine derivatives and their addition salts with an acid and at least one suitably selected coupler |
| 05/06/2005 | WO2005040355A2 Tao kinase modulators and methods of use |
| 05/06/2005 | WO2005040128A1 Heterocyclyl compounds |
| 05/06/2005 | WO2005040110A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2005 | WO2005040109A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/06/2005 | WO2005040108A1 Prolinamide derivatives as sodium and/or calcium channel blockers or selective mao-b inhibitors |
| 05/06/2005 | WO2005040101A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 05/06/2005 | WO2005019240A3 Melanin concentrating hormone receptor antagonists |
| 05/06/2005 | WO2005012249A3 Adamantyglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 05/06/2005 | WO2004113394A3 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | CA2543570A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 05/06/2005 | CA2542064A1 Tao kinase modulators and methods of use |
| 05/05/2005 | US20050096478 Derivatives of fluoro(hydro)carbons attached to an -alkylene-oxy-carbonyl-leaving group; reactive with amine-containing compounds to form a fluoro-substituted carbamyl protective group useful for the efficient separation, recovery and purification of synthsized organic compounds; libraries |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096466 Process for the preparation of tetrazol-derived compounds as growth hormone secretagogues |
| 05/05/2005 | US20050096358 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050096348 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 05/05/2005 | US20050096325 use of specified inhibitors of chemokine receptors to treat inflammatory diseases such as asthma, allergic rhinitis, atopic dermatitis, inflammatory bowel diseases, idiopathic pulmonary fibrosis, bullous pemphigoid, allergic colitis, eczema, conjunctivitis, familial eosinophilia |
| 05/05/2005 | US20050096312 Antiserotonine agents; antidepressants; eating disorders; anxiolytic agents; sleep disorders; gastrointestinal disorders; cardiovascular disorders; muscular disorders; endocrine system diseases; muscular disorders; psychological disorders |
| 05/05/2005 | US20050096309 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 05/04/2005 | EP1528055A2 Sulphonamide Derivatives |
| 05/04/2005 | EP1527207A1 Pyrrolyl complexes of copper for copper metal deposition |
| 05/04/2005 | EP1442022A4 Polyamide modulators of cox2 transcription |
| 05/04/2005 | CN1612887A Phosphino-aminophosphines |
| 05/04/2005 | CN1612859A Crystalline (r-(r*, r*))-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-heptanoic acid calcium salt (2:1) |
| 05/04/2005 | CN1612856A 1, 3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 05/04/2005 | CN1612732A Analgesics and methods of use |
| 05/04/2005 | CN1611524A Polyethylene glycol amino acid N-internal ring carbonyl anhydride active derivatives, and medicinal bonding compound and gel thereof |
| 05/04/2005 | CN1199945C Method for producing cyclic lactams |
| 05/03/2005 | US6888032 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 05/03/2005 | US6888006 Method for processing pyrollidone and n-vinyl pyrollidone residues |
| 05/03/2005 | US6887952 For use as cross-linking agents |
| 05/03/2005 | US6887893 Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia |
| 05/03/2005 | US6887887 Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 04/28/2005 | WO2005037826A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | WO2005037810A2 Cyclopropyl methanone derivatives, the preparation and the therapeutic use thereof |
| 04/28/2005 | WO2005037809A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | WO2005037786A1 Heterocyclyl compounds |
| 04/28/2005 | WO2005037785A2 Derivatives of n-[phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/28/2005 | WO2005037772A2 Novel ligand activating receptors rars used for human medicine and cosmetics |